Skip to main navigation
Skip to search
Skip to main content
Arizona State University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy
Stephen Massia (Inventor)
Arizona State University
Research output
:
Patent
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Dextrans
100%
Immunosuppressive Agents
74%
Anti-Inflammatory Agents
66%
Inflammation
52%
Autoimmune Diseases
46%
Eye
33%
Leukocytes
28%
Fluid Therapy
21%
Multiple Organ Failure
20%
Colloids
20%
Capillary Permeability
19%
Graft Rejection
19%
Immunologic Factors
19%
Eye Diseases
18%
Optic Nerve
18%
Septic Shock
18%
Wounds and Injuries
17%
Human Body
17%
Reperfusion Injury
17%
Retina
15%
Therapeutics
14%
Research Personnel
12%
Technology
11%
Equipment and Supplies
10%
Pharmaceutical Preparations
7%